These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 112831)

  • 21. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for coexistence of GABA and dopamine in neurons of the rat olfactory bulb.
    Gall CM; Hendry SH; Seroogy KB; Jones EG; Haycock JW
    J Comp Neurol; 1987 Dec; 266(3):307-18. PubMed ID: 2891733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of histamine H1- and H2-receptor agonists on gamma-aminobutyric acid (GABA) content in hypothalamus and striatum of the rat brain.
    Nowak JZ; Bielkiewicz B
    Arch Immunol Ther Exp (Warsz); 1980; 28(6):917-20. PubMed ID: 6455100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: implications for the therapy of Parkinson's disease.
    Bennett JP
    Ann Neurol; 1986 Feb; 19(2):194-7. PubMed ID: 3083762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex.
    Sesack SR; Snyder CL; Lewis DA
    J Comp Neurol; 1995 Dec; 363(2):264-80. PubMed ID: 8642074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of gamma-amino butyric acid and its receptor in the marginal division of rat striatum].
    Bao XM; Shu SY; Wang H
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):961-5. PubMed ID: 12433617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of drugs stimulating and blocking M and N cholinergic receptors on GABA level and GAD activity in rat striatum.
    Sieklucka-Dziuba M; Kleinrok Z
    Acta Physiol Pol; 1982; 33(5-6):567-75. PubMed ID: 7186759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of dopamine D1 and D2 receptors in the rat neostriatum: synaptic interaction with glutamate- and GABA-containing axonal terminals.
    Yung KK; Bolam JP
    Synapse; 2000 Dec; 38(4):413-20. PubMed ID: 11044888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex.
    Vincent SL; Adamec E; Sorensen I; Benes FM
    Synapse; 1994 May; 17(1):26-35. PubMed ID: 8042144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons.
    Martorana A; Fusco FR; Picconi B; Massa R; Bernardi G; Sancesario G
    Synapse; 2001 Sep; 41(4):360-2. PubMed ID: 11494407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dopamine concentration in the nigro-striatal system during elaboration and performance of conditioned avoidance reactions of various complexity in rats].
    Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1981 Jun; 67(6):797-803. PubMed ID: 7274479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique.
    Ottersen OP; Storm-Mathisen J
    J Comp Neurol; 1984 Nov; 229(3):374-92. PubMed ID: 6150049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry.
    Ribak CE; Vaughn JE; Roberts E
    J Comp Neurol; 1979 Sep; 187(2):261-83. PubMed ID: 226567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleus.
    Oertel WH; Riethmüller G; Mugnaini E; Schmechel DE; Weindl A; Gramsch C; Herz A
    Life Sci; 1983; 33 Suppl 1():73-6. PubMed ID: 6664248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA content of discrete brain nuclei and spinal cord of the rat.
    Van der Heyden JA; de Kloet ER; Korf J; Versteeg DH
    J Neurochem; 1979 Oct; 33(4):857-61. PubMed ID: 490160
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased interaction of dopamine-immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the postweanling period.
    Benes FM; Vincent SL; Molloy R; Khan Y
    Synapse; 1996 Aug; 23(4):237-45. PubMed ID: 8855508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.